https://scholars.lib.ntu.edu.tw/handle/123456789/560410
標題: | Loss of IKKβ activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis | 作者: | Yang P.-M. Huang W.-C. Lin Y.-C. Huang W.-Y. Wu H.-A. Chen W.-L. Chang Y.-F. Chou C.-W. Tzeng C.-C. Chen Y.-L. CHING-CHOW CHEN |
關鍵字: | IKKβ; P21; P53 | 公開日期: | 2010 | 卷: | 14 | 期: | 3 | 起(迄)頁: | 687-698 | 來源出版物: | Journal of Cellular and Molecular Medicine | 摘要: | Elevated levels of NF-κB are frequently detected in many inflammatory diseases and cancers. Blocking the IKK-NF-κB pathway has been seen as a promising approach for new therapies. By employing the dominant-negative mutant of IKKβ, our data revealed that loss of IKKβ activity reduces not only the proliferation and invasion of lung adenocarcinoma A549 cells in vitro but also the tumour formation, metastasis and angiogenesis in mouse xenograft model. Treatment of IKKβ inhibitors (CYL-19s and CYL-26z) leads to the arrest of cell cycle progression at G1 and G2/M, followed by apoptosis. IKKβ inhibitors can increase the protein stability, nuclear accumulation and promoter-binding activity of p53, leading to the p21 gene transcription. Furthermore, knockdown of IKKβ by siRNA increased the stability and expression of p53 and p21 promoter activity. In addition, IKKβ inhibitor-induced p53 and p21 expressions were augmented in the presence of IKKβ siRNA. Correlation between p53 acetylation and its protein stabilization was also seen after treatment with IKKβ inhibitors. These results suggest that loss of IKKβ activation is important for the enhancement of p53 stability, leading to p21 expression and cell cycle arrest and apoptosis of tumour cells. ? 2009 The Authors Journal compilation ? 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/560410 | ISSN: | 15821838 | DOI: | 10.1111/j.1582-4934.2009.00712.x | SDG/關鍵字: | 5 (4 acridin 9 ylamino)phenyl 5 methyl 3 methylenedihydrofuran 2 one; 5-(4-acridin-9-ylamino)phenyl-5-methyl-3-methylenedihydrofuran-2-one; acridine derivative; cyclin dependent kinase inhibitor 1A; furan derivative; I kappa B kinase; IKBKB protein, human; protein p53; animal; apoptosis; article; Bagg albino mouse; cell cycle; cell strain HCT116; drug antagonism; drug effect; experimental neoplasm; genetics; human; immunoblotting; metabolism; metastasis; mouse; neovascularization (pathology); nude mouse; pathology; physiology; protein stability; reverse transcription polymerase chain reaction; RNA interference; tumor cell line; xenograft; Acridines; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Furans; HCT116 Cells; Humans; I-kappa B Kinase; Immunoblotting; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasms, Experimental; Neovascularization, Pathologic; Protein Stability; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transplantation, Heterologous; Tumor Suppressor Protein p53 |
顯示於: | 藥理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。